search
Back to results

The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types

Primary Purpose

Ovarian Cysts

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Laparoscopic cystectomy
Sponsored by
Ege University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ovarian Cysts focused on measuring ovarian reserve, anti-mullerian hormone, ovarian cyst

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • no ovarian surgery before

Exclusion Criteria:

  • Endocrinological pathologies
  • Suspicion of malignancy in preoperative laboratory and ultrasonographic evaluations
  • Detection of malignancy in histopathological examination

Sites / Locations

  • Ege University Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Endometrioma

Mature cystic teratoma (dermoid cyst)

Serous or mucinous cystadenoma

Arm Description

Participants who will have endometrioma after histopathological evaluation.

Participants who will have mature cystic teratoma (dermoid cyst) after histopathological evaluation.

Participants who will have serous or mucinous cystadenoma after histopathological evaluation.

Outcomes

Primary Outcome Measures

Change in AMH Level
AMH levels of the participants will be investigated before the surgery and 6 months after the surgery.

Secondary Outcome Measures

Full Information

First Posted
September 19, 2021
Last Updated
September 3, 2022
Sponsor
Ege University
search

1. Study Identification

Unique Protocol Identification Number
NCT05054946
Brief Title
The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types
Official Title
The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2021 (Actual)
Primary Completion Date
September 1, 2022 (Actual)
Study Completion Date
September 1, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ege University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of our study is to compare the effect of laparoscopic ovarian cystectomy on ovarian reserve in terms of different cyst types.
Detailed Description
Participants who will be treated surgically for ovarian cysts will be included in the study. Anti-Mullerian Hormone (AMH) levels of the participants will be investigated before the surgery and 6 months after the surgery. All surgeries will be performed under general anesthesia laparoscopically. After histopathological evaluation, the participants will be divided into three groups; Group 1: Endometrioma, Group 2: Mature cystic teratoma (Dermoid cyst) and Group 3: Serous or mucinous cystadenoma. A total of fifty-five women will be included in the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ovarian Cysts
Keywords
ovarian reserve, anti-mullerian hormone, ovarian cyst

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
55 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Endometrioma
Arm Type
Active Comparator
Arm Description
Participants who will have endometrioma after histopathological evaluation.
Arm Title
Mature cystic teratoma (dermoid cyst)
Arm Type
Active Comparator
Arm Description
Participants who will have mature cystic teratoma (dermoid cyst) after histopathological evaluation.
Arm Title
Serous or mucinous cystadenoma
Arm Type
Active Comparator
Arm Description
Participants who will have serous or mucinous cystadenoma after histopathological evaluation.
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic cystectomy
Intervention Description
All surgeries will be performed under general anesthesia by laparoscopically.
Primary Outcome Measure Information:
Title
Change in AMH Level
Description
AMH levels of the participants will be investigated before the surgery and 6 months after the surgery.
Time Frame
6 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: no ovarian surgery before Exclusion Criteria: Endocrinological pathologies Suspicion of malignancy in preoperative laboratory and ultrasonographic evaluations Detection of malignancy in histopathological examination
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sabahattin Anil Ari, MD
Organizational Affiliation
Ege University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ege University Hospital
City
İzmir
ZIP/Postal Code
35100
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types

We'll reach out to this number within 24 hrs